1. Electrochemotherapy for basal cell carcinoma in the head and neck region : 5-year follow-up from the Insp-ECT registryAleš Grošelj, Giulia Bertino, Marta Minuti, James A. P. Clover, Camilla Kjaer Lonkvist, Erika Kis, Christian Kunte, Tobian Muir, Francesco Russano,, Francesca De Terlizzi, Joy Odili, Gregor Serša, 2025, original scientific article Abstract: Basal cell carcinoma (BCC) is a cutaneous malignancy that typically appears in sun-exposed areas. We analyzed data from the Insp-ECT registry of all patients affected by BCC in the head and neck region. The aim of this study was to evaluate the safety and efficacy of electrochemotherapy (ECT) on a 5-year basis. Patients and methods A cohort of 132 patients was included. They were treated by ECT according to the current Standard Operating Procedures. The median age was 74 years (range 41–93). There was a median of 1 nodule per patient (range 1–7), and the median size of the lesions was 1.4 cm (range 0.5–5.0 cm). Results Patients tolerated ECT well, and 96% agreed to repeat it if needed. The side effects were mild and temporary. All patients achieved a complete clinical response after 1 to 3 ECT sessions. During the first year of follow-up, 4 (3%) patients experienced recurrence, which was treated (2 with ECT, 1 with surgery, and 1 with a combination of ECT and surgery), after which they remained free of disease until the end of follow-up at 5 years. Five patients reported recurrence thereafter and were treated according to their condition. At the 5-year follow-up, the disease-free survival (DFS) rate was 92% (95% confidence interval [CI]: 87%–96%). At that time, 3 patients were alive with disease (2%), and 124 patients were free of disease (98%). Conclusions This study shows the feasibility and efficacy of ECT treatment in elderly patients with BCC tumors in aesthetically and functionally sensitive areas, with negligible toxicity. Comparable efficacy to other treatment modalities was demonstrated at 1 year and 5 years of follow-up in terms of DFS. Keywords: basal cell carcinoma, electrochemotherapy, preživetje brez ponovitve bolezni Published in DiRROS: 25.11.2025; Views: 297; Downloads: 98
Full text (894,67 KB) This document has many files! More... |
2. |
3. |
4. Breme kožnega raka v SlovenijiBarbara Perić, Vesna Zadnik, Mateja Krajc, 2024, published professional conference contribution (invited lecture) Keywords: rak (medicina), melanom, kožne bolezni, ultrazvočno sevanje, zaščita, preprečevanje bolezni Published in DiRROS: 23.01.2025; Views: 652; Downloads: 233
Full text (88,62 KB) |
5. |
6. UvodnikMateja Krajc, 2024, preface, editorial, afterword Keywords: rak (medicina), melanom, kožne bolezni, ultrazvočno sevanje, zaščita, preprečevanje bolezni Published in DiRROS: 23.01.2025; Views: 554; Downloads: 223
Full text (43,40 KB) |
7. Zakaj toliko besed o krompirju?Valentina Levak, Tjaša Lukan, 2024, popular article Keywords: krompir, zgodovina krompirja, krompirjevi škodljivci, krompirjeve bolezni, raziskave krompirja, Nacionalni inštitut za biologijo, sistemska biologija Published in DiRROS: 02.12.2024; Views: 718; Downloads: 769
Full text (1,69 MB) This document has many files! More... |
8. Poročilo o preskusu št.: LVG 2024-094 : vzorec št. 2024/00263Barbara Piškur, Zina Devetak, Patricija Podkrajšek, Špela Hočevar, Nikica Ogris, 2024, expertise, arbitration decision Keywords: varstvo gozdov, morfološke analize, ruj, traheomikoza, bolezni rastlin, verticilijska uvelost listavcev Published in DiRROS: 27.08.2024; Views: 814; Downloads: 250
Full text (1,17 MB) |
9. Obsevanje benignih bolezniIvica Ratoša, Blaž Grošelj, Boris Jančar, Uroš Smrdel, Jasna But-Hadžić, Helena Barbara Zobec Logar, 2024, review article Abstract: Cilja zdravljenja z obsevanjem benignih bolezni sta povrnitev funkcije in izboljšanje kakovosti življenja. Obsevanje benignih bolezni se običajno izvaja z nizko dnevno in celokupno obsevalno dozo. V primerjavi z dozo, ki se jo uporablja za zdravljenje malignih obolenj, je doza tukaj navadno precej nižja. S sodobnimi obsevalni-mi tehnikami, ki se uporabljajo v radioterapiji v zadnjem desetletju, je tveganje za poškodbe zdravega tkiva majhno. Z natančnim načrtovanjem obsevanja se žarki usmerijo na prizadeto območje, kar omogoča ohranitev zdravih tkiv. Obsevanje je tako varno in učinkovito, a je treba kljub temu vedno oceniti, kdaj je dobrobit obsevanja večja od morebitnih neželenih učinkov. Keywords: obsevanje, benigne bolezni, bolečina Published in DiRROS: 26.07.2024; Views: 1117; Downloads: 434
Full text (4,38 MB) |
10. Spremljanje bolnic z ginekološkimi raki po zaključenem zdravljenjuDarja Arko, 2024, published professional conference contribution Abstract: Število žensk, ki so se zdravile zaradi ginekoloških rakov, se veča zaradi staranje populacije, zgodnjega odkrivanja bolezni in bolj uspešnih načinov zdravljenja. Rak in zdravljenje raka prizadenejo ženske na več nivojih, fizično in psihično. Najpogostejše težave so kronične bolečine, utrujenost, limfedem, nevropatija, anksioznost in depresija. Ginekološki raki in njihovo zdravljenje imajo dodatno še pomemben negativen vpliv tudi na spolno življenje. Spremljanje bolnic po zdravljenju raka zato ni namenjeno samo zgodnjemu odkrivanju morebitne ponovitve bolezni, ampak tudi zagotavljanju čim boljše kakovosti življenja. Pomembno in potrebno je, da pri bolnicah po zdravljenju ginekoloških rakov prepoznamo in lajšamo težave, ki so posledica bodisi bolezni same ali pa posledica zdravljenja raka. Načini in organizacija spremljanja bolnic z ginekološkimi raki se močno razlikuje med posameznimi centri in državami, jasnih dokazov, kateri je najboljši način dela, ni. Verjetnost ponovitve bolezni se razlikuje glede na vrsto raka, stadij bolezni, stanje bolnice in glede na to, kako je bila zdravljena, zato je tudi spremljanje smiselno prilagoditi posameznici, kar poudarja večina sodobnih smernic. Ginekološki raki predstavljajo heterogeno skupino bolezni. Mednarodna in domača priporočila o spremljanju so narejena za posamezne lokalizacije in so na kratko predstavljena v prispevku. Keywords: rak (medicina), ginekologija, ponovitev bolezni, kakovost življenja, strokovna priporočila Published in DiRROS: 04.06.2024; Views: 1110; Downloads: 368
Full text (50,31 KB) |